Anti-Reflux Surgery Promising in Idiopathic Pulmonary Fibrosis

Share this content:
Anti-Reflux Surgery Promising in Idiopathic Pulmonary Fibrosis
Anti-Reflux Surgery Promising in Idiopathic Pulmonary Fibrosis

MONDAY, Oct. 1, 2018 (HealthDay News) -- Laparoscopic antireflux surgery is safe and well-tolerated in patients with idiopathic pulmonary fibrosis (IPF) and abnormal acid gastroesophageal reflux (GER), according to a phase 2 study published in the Sept. 1 issue of The Lancet Respiratory Medicine.

Ganesh Raghu, M.D., from the University of Washington in Seattle, and colleagues performed a randomized controlled trial to assess whether treatment of abnormal acid GER with laparoscopic antireflux surgery reduced the rate of disease progression among 29 patients with IPF and abnormal acid GER recruited from six U.S. academic centers versus those not receiving surgery (29 patients).

After adjusting for baseline anti-fibrotic use in an intention-to-treat analysis, the researchers found that the rate of change in forced vital capacity over 48 weeks was −0.05 L (95 percent confidence interval, −0.15 to 0.05) in the surgery group and −0.13 L (95 percent confidence interval, −0.23 to −0.02) in the non-surgery group (P = 0.28). In the surgery group, acute exacerbation, respiratory-related hospitalization, and death were less common without statistical significance. The most common adverse events after surgery included dysphagia (29 percent) and abdominal distention (14 percent). In addition, there was one death in the surgery group and four deaths in the non-surgery group.

"A larger, well-powered, randomized controlled study of antireflux surgery is needed in this population," the authors write.

Several authors disclosed financial ties to the pharmaceutical industry.

Abstract/Full Text
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

CDC: Increase Seen in Salmonella Illnesses From Ground Beef

CDC: Increase Seen in <i>Salmonella</i> Illnesses From Ground ...

246 people now sickened; 59 people have been hospitalized; no deaths reported to date

Epinephrine Personal Autoinjectors Cost-Effective at 24

Epinephrine Personal Autoinjectors Cost-Effective at &#36;24

Based on 10-fold fatality risk difference, value-based price for personal epinephrine $24

Burden of Liver Cancer Rising in Medicare Patients

Burden of Liver Cancer Rising in Medicare Patients

Coexistence of other liver conditions tied to even higher risk for death, health care costs

is free, fast, and customized just for you!




Already a member?

Sign In Now »